OverviewClinical Development Director (CDD) – 18 month Contract – Hybrid or remote.The Clinical Development Director (CDD) is the clinical/scientific and clinical development expert and provides leadership and support to clinical development deliverables and activities within a defined global clinical development program and/or global clinical trial (e.g., clinical development plan, clinical trial protocol), under the leadership of the GPCH. Major Activities

Supports and if assigned leads delivery of all assigned clinical deliverables in the assigned section of a clinical program. Clinical deliverables may include the clinical development strategy for assigned program section(s), clinical sections of individual protocols consistent with the Integrated Development Plans (IDP), clinical data review and program specific standards, clinical components of regulatory documents/registration dossiers, and publications. Provides input into final analyses and interpretation including the development of the Clinical Study Report(s) (CSRs), publications and internal/external presentations. Leads development of clinical sections of trial and program level regulatory documents (e.g., Investigator's Brochures, briefing books, safety updates, submission dossiers, and responses to Health Authorities). Oversees/conducts ongoing clinical and scientific review of clinical trial data with medical monitor, Clinical Scientific Expert(s) with appropriate oversight from Medical Lead. Works in close collaboration with the data management and statistics teams to ensure proper data quality and analysis of clinical trial results. Inspections readiness and interaction with QA - risk assessments, audit preparation, mock interviews, storyboard and presentation prep; author and/or review abstracts, presentations and manuscripts for accuracy of clinical data and content. May be the Program Manager of other associates (e.g., CSE). Provides support to Sr CDMD and/or GPCH in monitoring and safety data and signals the molecule for the assigned section of the clinical trial; may be a member of the Safety Management Team (SMT), and supports overall program safety reporting (e.g., PSURs, DSURs, and other safety related documents) in collaboration with the medical monitor, CDMD and Patient Safety Major Activities CDD. As a clinical development expert, may support the GPCH or CDH in interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring boards, advisory boards, patient advocacy groups), internal stakeholders (e.g., CTT, Research, Translational Medicine, Global Medical Affairs, Marketing, HE&OR), and internal decision boards. May work with Biomedical Research/Translational Medical Sciences to drive transition of pre-PoC (Proof of Concept) projects to DDP (Development Decision Point) and with BD&L including target identification and due diligences together with other medical matters, as assigned. Ensures career development of Program reports and other clinical colleagues through active participation in the performance management and talent planning processes. Provides onboarding, training, and mentoring support. Contributes to medical/scientific training of relevant Client's stakeholders on the disease area and compound/molecule. May serve as speaker for franchise medical/scientific training. May serve on or lead global initiatives (e.g., process improvement, training, SOP development, other Clinical Development line function initiatives). May be assigned to lead clinical trial(s) as Clinical Scientific Lead and provide leadership and guidance for all clinical aspects of a clinical trial in close collaboration with the assigned medical monitor and/or CDMD.

KPIs

Timely delivery of high quality IDP/CDP sections, CTPs, and other clinical deliverables aligned with IDP/CDP and TPP and endorsed by review committees and internal boards, with acceptance by key external and internal stakeholders. Applies effective clinical research methodology, including trial/analyses, efficacy endpoints, safety assessments, and risk management across disease area and development phases. Strong evidence of quality clinical/scientific review of trial data; lead TA through high quality IDP and protocol reviews; timely development of quality disease/program clinical standards, publications, internal/external presentations, and other CD deliverables. Strong evidence of quality contributions to and acceptance of clinical sections of regulatory documents, Investigators' Brochures, briefing books, safety updates, and submission dossiers by key external and internal stakeholders. Well managed, effective, and engaged clinical teams; demonstrated ability to deputize for GPCH at GCT, as well as other venues as needed. Clearly demonstrates Client Values and Behaviours.

Number of associates: May lead team of approx. 3 direct and indirect reports (dependent on the size of the programs and functional responsibilities). Financial responsibility: Overall lifetime clinical budget of program which can vary and be in excess of $20 million. Impact on the organization External

Timely submission and delivery of high-quality clinical program data supporting regulatory approval of key compounds (or new indications), as appropriate. Effective interaction with and influence on key external decision makers (e.g., regulatory authorities, medical experts, pricing and reimbursement bodies).

Internal

Clinically and scientifically sound programs and trials resulting in the timely delivery of high-quality data and analysis of trial data which enables strategic decisions within the clinical program. High quality clinical/scientific review of CTPs and CDPs, industry leading clinical processes. Identification and development of key talent.

Ideal Background Experience/Professional requirement:

≥ 7 years of involvement in clinical research or drug development in an academic or industry environment spanning clinical activities in Phases I through IV. ≥ 3 years of contribution to and accomplishment in all aspects of conducting clinical trials (e.g., planning, executing, reporting and publishing) in a global/matrix environment in pharmaceutical industry. Advanced knowledge of assigned therapeutic area. Demonstrated ability to establish strong scientific partnership with key stakeholders. Thorough knowledge of GCP, clinical trial design and methodology, statistical analysis methodology, and regulatory/clinical development process. Around 1 year of People management experience preferred; global people management experience desirable. Excellent communication skills, written and oral; excellent interpersonal skills; excellent negotiation and conflict resolution skills.

Note: Carbon60, Lorien & SRG - The Impellam Group STEM Portfolio are acting as an Employment Business in relation to this vacancy. #J-18808-Ljbffr